Molecular targets of selenium in prostate cancer prevention (Review)

  • Authors:
    • Rizky Abdulah
    • Kenji Kobayashi
    • Chiho Yamazaki
    • Hiroshi Koyama
  • View Affiliations

  • Published online on: May 10, 2011     https://doi.org/10.3892/ijo.2011.1035
  • Pages: 301-309
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Prostate cancer is one of the leading causes of cancer-related deaths among males. Although use of the micro-nutrient selenium in prostate cancer clinical trials is limited, the outcomes indicate that selenium is a promising treatment. Furthermore, selenium inhibits prostate cancer through multiple mechanisms, and it is beneficial in controlling the development of this disease. This review highlights the latest epidemiological and biomolecular research on selenium in prostate cancer, as well as its prospects for future clinical use.

Related Articles

Journal Cover

August 2011
Volume 39 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Abdulah R, Kobayashi K, Yamazaki C and Koyama H: Molecular targets of selenium in prostate cancer prevention (Review). Int J Oncol 39: 301-309, 2011
APA
Abdulah, R., Kobayashi, K., Yamazaki, C., & Koyama, H. (2011). Molecular targets of selenium in prostate cancer prevention (Review). International Journal of Oncology, 39, 301-309. https://doi.org/10.3892/ijo.2011.1035
MLA
Abdulah, R., Kobayashi, K., Yamazaki, C., Koyama, H."Molecular targets of selenium in prostate cancer prevention (Review)". International Journal of Oncology 39.2 (2011): 301-309.
Chicago
Abdulah, R., Kobayashi, K., Yamazaki, C., Koyama, H."Molecular targets of selenium in prostate cancer prevention (Review)". International Journal of Oncology 39, no. 2 (2011): 301-309. https://doi.org/10.3892/ijo.2011.1035